|
Tuesday 1st November 2016 |
Text too small? |
Trilogy International, the cosmetics brand and distributor, has told the NZX it continues to comply with the stock market's rules on continuous disclosure, following a fall in its share price.
In a letter to Trilogy, the NZX noted that Trilogy's shares had fallen from $3.85 at the market close on Oct 25, to $3.30 in trading this morning, a fall of 55 cents or 14.3 percent.
Lindsay Render, the Chief Financial Officer for Trilogy responded that it continues to meet its obligations.
Shares in Trilogy reached $4.92 on Aug 16, but it has tumbled since, in a period in which it listed on the ASX and released profits guidance that underwhelmed some investors. It closed up 6 cents or 1.8 percent at $3.46 and has risen 94 percent since a year ago.
BusinessDesk.co.nz
No comments yet
Metro Performance Glass FY26 Market Update
Devon Funds Morning Note - 13 March 2026
Devon Funds Morning Note - 12 March 2026
TCM - Financial Model
BRM - Scheme of Arrangement Update - NZ Commerce Commission
Devon Funds Morning Note - 11 March 2026
BGP - Full Year Results to 25 January 2026
BRM - Scheme of Arrangement Update - NZ Commerce Commission
The oil shock
Air New Zealand suspends FY2026 guidance